153 related articles for article (PubMed ID: 38285771)
1. Type 2 Diabetes Mellitus and Non-Metastatic Colorectal Cancer: A Retrospective Study on Survival and Toxicity Profiles.
Elabd NS; Alabassy MM; Seddik RM; Amer AA; Abdelaziz RA; Sohaib A
Asian Pac J Cancer Prev; 2024 Jan; 25(1):87-94. PubMed ID: 38285771
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in patients with type 2 diabetes mellitus: a single-center experience.
Sinagra E; Guarnotta V; Raimondo D; Mocciaro F; Dolcimascolo S; Rizzolo CA; Puccia F; Maltese N; Citarrella R; Messina M; Spada M; Tomasello G; Cappello F; Leone A; Rossi F; Di Mitri R; Morreale GC; Marasà S; Midiri M; Midiri F; Sinagra D
J Biol Regul Homeost Agents; 2017; 31(4):1101-1107. PubMed ID: 29254321
[TBL] [Abstract][Full Text] [Related]
3. Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes.
Herold M; Szasz AM; Szentmartoni G; Martinek E; Madar-Dank V; Barna AJ; Mohacsi R; Somogyi A; Dank M; Herold Z
Sci Rep; 2023 Aug; 13(1):12985. PubMed ID: 37563292
[TBL] [Abstract][Full Text] [Related]
4. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
5. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.
Siddiqui AA; Spechler SJ; Huerta S; Dredar S; Little BB; Cryer B
Dig Dis Sci; 2008 Sep; 53(9):2486-94. PubMed ID: 18409001
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer.
Miranda Baleiras M; Dias Domingues T; Severino E; Vasques C; Neves MT; Ferreira A; Vasconcelos de Matos L; Ferreira F; Miranda H; Martins A
Cureus; 2023 Jan; 15(1):e33916. PubMed ID: 36819384
[TBL] [Abstract][Full Text] [Related]
7. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation.
de Kort S; Masclee AAM; Sanduleanu S; Weijenberg MP; van Herk-Sukel MPP; Oldenhof NJJ; van den Bergh JPW; Haak HR; Janssen-Heijnen ML
Sci Rep; 2017 Apr; 7():46527. PubMed ID: 28436468
[TBL] [Abstract][Full Text] [Related]
8. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
[No Abstract] [Full Text] [Related]
10. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China.
Ren X; Zhang X; Zhang X; Gu W; Chen K; Le Y; Lai M; Zhu Y
Public Health; 2009 Aug; 123(8):540-4. PubMed ID: 19664792
[TBL] [Abstract][Full Text] [Related]
11. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of stage iv colorectal cancer patients after primary surgery: a propensity score matching analysis.
Liu XR; Liu F; Li ZW; Liu XY; Zhang W; Peng D
Int J Colorectal Dis; 2023 Jun; 38(1):171. PubMed ID: 37330453
[TBL] [Abstract][Full Text] [Related]
12. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies.
Abdel-Rahman O
Clin Transl Oncol; 2019 Apr; 21(4):512-518. PubMed ID: 30182209
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.
de Kort S; Simons CC; van den Brandt PA; Goldbohm RA; Arts IC; de Bruine AP; Janssen-Heijnen ML; Sanduleanu S; Masclee AA; Weijenberg MP
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):896-903. PubMed ID: 27097356
[TBL] [Abstract][Full Text] [Related]
15. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients.
Wang R; Liu R; Zhao L; Xu D; Hu L
Rev Esp Enferm Dig; 2017 Jul; 109(7):503-509. PubMed ID: 28593781
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Diabetes Mellitus After Colorectal Cancer Surgery: A Retrospective Study of Predictive Factors For Type 2 Diabetes Mellitus Remission and Overall Survival.
Peng D; Liu XY; Cheng YX; Tao W; Cheng Y
Front Oncol; 2021; 11():694997. PubMed ID: 34295822
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].
Cai Y; Deng R; Hu H; Zhang J; Ling J; Wu Z; Yang L; Li J; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1045-1050. PubMed ID: 30269326
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer.
McCleary NJ; Odejide O; Szymonifka J; Ryan D; Hezel A; Meyerhardt JA
Clin Colorectal Cancer; 2013 Mar; 12(1):62-9. PubMed ID: 23102897
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological characteristics of colorectal cancer complicated with type 2 diabetes mellitus: analysis of clinicopathological data from 3, 202 colorectal cancer patients].
Liu R; Hu L; Li G; Zhao L; Li S; Zhang X; Zhang Q; Wu L
Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):74-7. PubMed ID: 24685092
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status.
Cavicchia PP; Adams SA; Steck SE; Hussey JR; Liu J; Daguisé VG; Hebert JR
Cancer Causes Control; 2013 Feb; 24(2):277-85. PubMed ID: 23197224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
